Name | MUNITSIPAL'NOE UNITARNOE PREDPRIYATIE "APTEKA N 1" |
---|
INN | 0105018615 |
---|
KPP | 010501001 |
---|
OGRN | 1020100710057 |
---|
OKPO | 39681418 |
---|
Address | 385018, Respublika Adygeya (Adygeya), Maykop, ul. Dimitrova, d. 21 |
---|
Phone | +7 (877) 253-60-83 Contact details |
---|
Fax | 3-60-83 |
|
OKVED code | Type | Name of activity type |
---|
47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | 21.20 | Additional activity | Manufacturers of drugs and pharmaceuticals and medical products | 46.46 | Additional activity | Wholesale of pharmaceutical goods | All types of activities | 70.22 | Additional activity | Advice on business and management | 73.11 | Additional activity | Activities of advertising agencies |
Registration date | 27.12.2002 |
---|
Registering department | Administratsiya g. Maykopa Respubliki Adygeya |
---|
|
MUP "APTEKA N 1" (Adygea, Republic; INN 0105018615) was registered on 27 Dec 2002. The company's authorized capital as of July 1, 2012 was 100000 rub. Type of ownership of MUP "APTEKA N 1" - Unitary enterprises based on the principle of economic management. Form of ownership of MUP "APTEKA N 1" - Municipal property. Principal activities of MUP "APTEKA N 1": retailing drugs in specialized stores (pharmacies) (47.73), manufacturers of drugs and pharmaceuticals and medical products (21.20), wholesale of pharmaceutical goods (46.46). |
Economic indicators2022
Net profit (RAS) of MUP APTEKA N 1 dropped in 2022 6.75 times to 4.00 thousand RUB from 27.00 thousand RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 28.85% to 16.69 million RUB from 23.46 million RUB in 2021; cost of goods sold decreased by 39.20% to 9.78 million RUB from 16.09 million RUB; sales loss decreased 3.00 times to 1.90 million RUB from 5.69 million RUB. 2021
Net profit (RAS) of MUP APTEKA N 1 grew over 2021 by 28.57% to 27.00 thousand RUB from 21.00 thousand RUB over 2020, the company informed. Revenue decreased in the accounting period by 10.60% to 23.46 million RUB from 26.24 million RUB in 2020; cost of goods sold decreased by 11.25% to 16.09 million RUB from 18.13 million RUB; sales loss grew by 33.79% to 5.69 million RUB from 4.26 million RUB. 2020
Net profit (RAS) of MUP APTEKA N 1 dropped in 2020 2.33 times to 21.00 thousand RUB from 49.00 thousand RUB over the same period in 2019, the company informed. Revenue decreased in the accounting period by 19.30% to 26.24 million RUB from 32.52 million RUB in 2019; cost of goods sold decreased by 14.92% to 18.13 million RUB from 21.31 million RUB; sales loss grew by 40.55% to 4.26 million RUB from 3.03 million RUB. 2019
Net profit (RAS) of MUP APTEKA N 1 grew over 2019 2.72 times to 49.00 thousand RUB from 18.00 thousand RUB over 2018, the company informed. Revenue decreased in the accounting period by 6.67% to 32.52 million RUB from 34.85 million RUB in 2018; cost of goods sold decreased by 15.81% to 21.31 million RUB from 25.31 million RUB; sales loss decreased by 30.57% to 3.03 million RUB from 4.36 million RUB. 2018
Net profit (RAS) of MUP APTEKA N 1 dropped in 2018 12.67 times to 18.00 thousand RUB from 228.00 thousand RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 8.52% to 34.85 million RUB from 38.09 million RUB in 2017; cost of goods sold decreased by 7.72% to 25.31 million RUB from 27.43 million RUB; sales loss grew by 25.35% to 4.36 million RUB from 3.48 million RUB. 2017
Net profit (RAS) of MUP APTEKA N 1 dropped in 2017 by 20.83% to 228.00 thousand RUB from 288.00 thousand RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 14.66% to 38.09 million RUB from 44.63 million RUB in 2016; cost of goods sold decreased by 17.02% to 27.43 million RUB from 33.06 million RUB; sales loss grew by 27.81% to 3.48 million RUB from 2.72 million RUB. 2016
Net profit (RAS) of MUP APTEKA N 1 dropped in 2016 by 4.95% to 288.00 thousand RUB from 303.00 thousand RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 9.83% to 44.63 million RUB from 49.50 million RUB in 2015; cost of goods sold decreased by 11.18% to 33.06 million RUB from 37.22 million RUB; sales loss grew by 20.12% to 2.72 million RUB from 2.27 million RUB. 2014
Net profit (RAS) of MUP Apteka N 1 grew over 2014 by 2.15% to 190.00 thousand RUB from 186.00 thousand RUB over 2013, the company informed. Revenue decreased in the accounting period by 4.67% to 45.00 million RUB from 47.20 million RUB in 2013; cost of goods sold decreased by 6.02% to 33.80 million RUB from 35.97 million RUB; sales loss decreased by 4.30% to 2.43 million RUB from 2.54 million RUB. 2013
Net profit (RAS) of MUP Apteka N 1 grew over 2013 1.92 times to 186.00 thousand RUB from 97.00 thousand RUB over 2012, the company informed. Revenue increased in the accounting period by 13.52% to 47.20 million RUB from 41.58 million RUB over 2012; cost of goods sold grew by 14.24% to 35.97 million RUB from 31.48 million RUB; sales loss decreased by 7.14% to 2.54 million RUB from 2.73 million RUB. 2012
Net profit (RAS) of MUP Apteka N 1 grew over 2012 2.55 times to 97.00 thousand RUB from 38.00 thousand RUB over 2011, the company informed. Cost of goods sold grew by 12.16% to 31.48 million RUB from 28.07 million RUB; sales loss decreased by 12.58% to 2.73 million RUB from 3.12 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|